U-2940, a human B-cell line derived from a diffuse large cell lymphoma sequential to Hodgkin lymphoma

International Journal of Cancer

Volumn 118, Issue 3, 2006, Pages 555-563

  Sambade, Clara ^a,b   Berglund, Mattias ^c,d   Lagercrantz, Svetlana ^d   Sällström, Jan ^c   Reis, Rui M ^a   Enblad, Gunilla ^c   Glimelius, Bengt ^c   Sundström, Christer ^c  

^a UNIVERSITY OF PORTO   (Portugal)

^b Faculty of Engineering of Porto   (Portugal)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Composite lymphomas; Diffuse large B cell lymphoma; Hodgkin lymphoma; Lymphomagenesis

Indexed keywords

BLEOMYCIN; CHLORMETHINE; DACARBAZINE; DNA; DOXORUBICIN; IMMUNOGLOBULIN HEAVY CHAIN; PREDNISONE; RNA; VINBLASTINE; VINCRISTINE;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B CELL LYMPHOMA; CANCER CELL CULTURE; CANCER COMBINATION CHEMOTHERAPY; CARCINOGENICITY; CELL STRAIN U 2940; CHROMOSOME REARRANGEMENT; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; FEMALE; HODGKIN DISEASE; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; MEDIASTINUM TUMOR; MICROSATELLITE INSTABILITY; MOUSE; NONHODGKIN LYMPHOMA; NONHUMAN; PHENOTYPE; PLEURA EFFUSION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADOLESCENT; ANIMALS; CELL LINE, TUMOR; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 18; COLONY-FORMING UNITS ASSAY; DNA, NEOPLASM; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GENE REARRANGEMENT; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; MEDIASTINAL NEOPLASMS; MICE; MICE, NUDE; NEOPLASMS, SECOND PRIMARY; SPECTRAL KARYOTYPING; TRANSLOCATION, GENETIC;

EID: 30444435933     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.21417     Document Type: Article

References (52)

1. Krikorian JG, Burke JS, Rosenberg AS, Kaplan HS. Occurrence of non-Hodgkin's lymphoma after therapy for Hodgkin's disease. N Engl J Med 1979;300:452-8.
2. Zarate-Osorno A, Medeiros LJ, Longo DL, Jaffe ES. Non-Hodgkin's lymphomas arising in patients successfully treated for Hodgkin's disease: a clinical, histologic, and immunophenotypic study of 14 cases. Am J Surg Pathol 1992;16:885-95.
3. Rueffer U, Josting A, Franklin J, May M, Sieber M, Breuer K, Engert A, Diehl V. Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: incidence, treatment, and prognosis. J Clin Oncol 2001;19:2026-32.
4. Jaffe ES, Zarate-Osomo A, Medeiros J. The interrelationship of Hodgkin's disease and non-Hodgkin's lymphomas: lessons learned from composite and sequential malignancies. Sem Diagn Pathol 1992;9:297-303.
5. Harris NL. The relationship between Hodgkin's disease and non-Hodgkin's lymphoma. Sem Diagn Pathol 1992;9:304-10.
6. Miettinen M, Franssila K, Saxén E. Hodgkin's disease, lymphocyte predominance nodular: increased risk for subsequent non-Hodgkin's lymphomas. Cancer 1983;51:2293-300.
7. Hansmann M-L, Stein H, Fellbaum C, Hui PK, Parwaresch MR, Lennert K. Nodular paragranuloma can transform into high-grade malignant lymphoma of B type. Hum Pathol 1989;20:1169-75.
8. Timens W, Visser L, Poppema S. Nodular lymphocyte predominance type of Hodgkin's disease is a germinal center lymphoma. Lab Invest 1986;54:457-61.
9. Tamaru J, Hummel M, Zemlin M, Kalelage B, Stein H. Hodgkin's disease with a B-cell phenotype often shows a VDJ rearrangement and somatic mutations in the VH genes. Blood 1994;84:708-15.
10. Delabie J, Tierens A, Wu G, Weisenburger DD, Chan WC. Lymphocyte predominance Hodgkin's disease: lineage and clonality determination using a single-cell assay. Blood 1994;84:3291-98.
11. Williams J, Sched A, Cotelingam JD, Jaffe ES. Chronic lymphocytic leukaemia with coexistent Hodgkin's disease: implications for the origin of the Reed-Sternberg cell. Am J Pathol 1991;15:33-42.
12. Momose H, Jaffe ES, Shin SS, Chen Y-Y, Weiss LM. Chronic lymphocytic leukaemia/small lymphocytic lymphoma with Reed-Sternberg-like cells and possible transformation to Hodgkin's disease: mediation by Epstein-Barr virus. Am J Pathol 1992;16:859-67.
13. Ohno T, Smir BN, Weisenburger DD, Gascoyne RD, Hinrichs SD, Chan WC. Origin of the Hodgkin/Reed-Sternberg cells in chronic lymphocytic leukaemia with "Hodgkin's transformation." Blood 1998;91:1757-61.
14. De Leval L, Vivario M, De Prijck B, Zhou Y, Boniver J, Harris NL, Isaacson P, Du M-Q. Distinct clonal origin in two cases of Hodgkin's lymphoma variant of Richter's syndrome associated with EBV infection. Am J Sur Pathol 2004;28:679-86.
15. Yoshinaga H, Ohashi K, Yamamoto K, Miki T, Miura O, Saito T, Koyama T, Kanazawa A, Nemoto T, Miyasaka N, Kamiyama R, Hirosawa S. Clonal identification of Burkitt's lymphoma arising from lymphocyte-predominant Hodgkin's disease. Br J Haematol 1996;95:380-2.
16. Bräuninger A, Hansmann M-L, Strickler JG, Dummer R, Burg G, Rajewsky K, Küppers R. Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma. N Engl J Med 1999;340:1239-47.
17. Marafioti T, Hummel M, Anagnostopoulos I, Foss H-D, Huhn D, Stein H. Classical Hodgkin's disease and follicular lymphoma originating from the same germinal center B cell. J Clin Oncol 1999;17:3804-9.
18. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature 1998;396:643-9.
19. Robledo M, Martinez B, Arranz E, Trujillo MJ, Ageitos AG, Rivas C, Benitez J. Genetic instability of microsatellites in hematological neoplasms. Leukemia 1995;9:960-4.
20. Gamberi B, Gaidano G, Parsa N, Carbone A, Roncella S, Knowles DM, Louie DC, Shibata D, Chaganti RSK, Dalla-Favera R. Microsatellite instability is rare in B-cell non-Hodgkin's lymphomas. Blood 1997;89:975-9.
21. de Wind N, Dekker M, Berns A, Radman M, te Riele H. Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer. Cell 1995;82:321-30.
22. Reitmar Ah, Schmits R, Ewel A, Bapat B, Redston M, Mitri A, Waterhouse P, Mittrucker HW, Wakeham A, Liu B, Thomason A, Griesser H, et al. HMSH2 deficient mice are viable and susceptible to lymphoid tumours. Nat Genet 1995;11:64-70.
23. Edelmann W, Yang K, Umar A, Heyer J, Lau K, Fan K, Liedtke W, Cohen PE, Kane MF, Lipford JR, Yu N, Crouse GF, et al. Mutation in the mismatch repair gene MSH6 causes cancer susceptibility. Cell 1997;91;467-77.
24. Reedman BM, Klein G. Cellular localization of na Epstein-Barr virus (EBV) associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. Int J Cancer 1973;11:499-520.
25. Berglund M, Enblad G, Flordal E, Lui WO, Backlin C, Thunberg U, Sundström C, Roos G, Allander SV, Erlanson M, Rosenquist R, Larsson C, et al. Chromosomal imbalances in diffuse large B-cell lymphoma detected by comparative genomic hybridization. Mod Pathol 2002;15:807-17.
26. Berglund M, Flordal E, Gullander J, Lui WO, Larsson C, Lagercrantz S, Enblad G. Molecular cytogenetic characterization of four commonly used cell lines derived from Hodgkin lymphoma. Cancer Genet Cytogenet 2003;141:43-8.
27. Sambade C, Sällström J, Wiklund H, Enblad G, Kivi S, Gartner F, Zech L, Glimelius B, Sundström C. A novel human B-cell line (U-2904) bearing t(8;14) and t(14;18) translocations. Int J Cancer 1995;63:710-15.
28. Thunberg U, Rosenquist R, Lindström A, Lindh J, Sundström C, Roos G, Sällström J. Comparative analysis of detection systems for evaluation of PCR amplified immunoglobulin heavy-chain gene rearrangements. Diagn Mol Pathol 1997;6:140-6.
29. Gribben JG, Neuberg D, Freedman AS, Gimmi CD, Pesek KW, Barber M, Saporito L, Woo SD, Coral F, Spector N. Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma. Blood 1993;81:3449-59.
30. Crescenzi M, Seto M, Herzig GP, Weiss PD, Griffith RC, Korsmeyer SJ. Thermostable DNA polymerase chain amplification of t(14;18) chromosome breakpoints and detection of minimal residual disease. Proc Natl Acad Sci USA 1988;13:4869-73.
31. Wagner HJ, Bein G, Bitsch A, Kirchner H. Detection and quantification of latently infected B lymphocytes in Epstein-Barr virus-seropositive, healthy individuals by polymerase chain reaction. J Clin Microbiol 1992;30:2826-9.
32. Soares P, Santos NR, Seruca R, Lothe RA, Sobrinho-Simões M. Benign and malignat thyroid lesions show instability at microsatellite loci. Eur J Cancer 1997;33:293-6.
33. Liu B, Nicolaides NC, Markowitz S, Willson JKV, Parsons RE, Jen J, Papadopolous N, Peltomaki P, de la Chapelle A, Hamilton SR, Kinzler KW, Vogelstein B. Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nat Genet 1995;9;48-55.
34. Rosenwald A, Wright G, Leroy K, Yu X, Gaulard P, Gascoyne RD, Chan WC, Zhao T, Haioun C, Greiner TC, Weisenburger DD, Lynch JC, et al. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin's lymphoma. J Exp Med 2003;198:851-62.
35. Savage KJ, Monti S, Kutok JL, Cattoretti G, Neuberg D, de Leval L, Kurtin P, Cin PD, Ladd C, Feuerhake F, Aguiar RC, Li S, et al. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin's lymphoma. Blood 2003;102:3871-9.
36. Möller P, Bruderlein S, Strater J, Leithauser F, Hasel C, Bataille F, Moldenhauer G, Pawlita M, Barth TFE. MedB-1, a human tumor cell line derived from a primary mediastinal large B-cell lymphoma. Int J Cancer 2001;92:348-53.
37. Küppers R, Schwering I, Bräuninger A, Rajewsky K, Hansmann M-L. Biology of Hodgkin's lymphoma. Ann Oncol 2002;13(Suppl 1):11-8.
38. Wickert RS, Weisenburger A, Tierens A, Greiner TC, Chan WC. Clonal relationship between lymphocytic predominance Hodgkin's disease and concurrent or subsequent large-cell lymphoma of B lineage. Blood 1995;86:2312-20.
39. Greiner TC, Gascoyne RD, Anderson ME, Kingma DW, Adomat AS, Said J, Jaffe ES. Nodular lymphocyte-predominant Hodgkin's disease associated with large-cell lymphoma: analysis of Ig gene rearrangements by V-J polymerase chain reaction. Blood 1996;88:657-66.
40. Tinguely M, Rosenquist R, Sundström C, Amini R-M, Küppers R, Hansmann M-L, Bräuninger A. Analysis of a clonally related mantle cell and Hodgkin lymphoma indicates Epstein-Barr virus infection of a Hodgkin/Reed-Sternberg cell precursor in a germinal centre. Am J Surg Pathol 2003;27:1483-8.
41. Amini R-M, Berglund M, Rosenquist R, von Heidemann A, Lagercrantz S, Thunberg U, Bergh J, Sundström C, Glimelius B, Enblad G. A novel B-cell line (U-2932) established from a patient with diffuse large B-cell lymphoma following Hodgkin lymphoma. Leukemia Lymphoma 2002;43:2179-89.
42. Bernell P, Jacobsson B, Hjalmar V, Arvidsson V, Hast R. Gain of chromosome 7 marks the progression from indolent to aggressive follicle centre lymphoma and is a common finding in patients with diffuse large B-cell lymphoma: a study by FISH. Br J Haematol 1998;101:487-91.
43. Okkenhaug K, Vanhaesebroeck B. PI3K in lymphocyte development, differentiation and activation. Nat Rev Immun 2003;3:317-30.
44. Anzelon AN, Wu H, Rickert RC. Pten inactivation alters peripheral B lymphocyte fate and reconstitutes CD19 function. Nat Immun 2003;4:287-94.
45. DeCoteau LF, Reis MD, Griesser H, Lorenzana A, Al-Hashmi I, Hawley RG, Naumov A, White CA, Pinkerton PH. SBH-1, a novel Reed-Sternberg-like cell line capable of inducing tumors in SCID mice: immunophenotypic, cytogenetic, and cytokine expression profiles. Blood 1995;85:2829-38.
46. Falzetti D, Crescenzi B, Matteucci C, Falini B, Martelli MF, van der Berghe H, Mecucci C. Genome instability and recurrent breakpoints are main cytogenetic findings in Hodgkin's disease. Haematologica 1999;84:298-305.
47. Cabanillas F, Pathak S, Trujillo J, Grant G, Cork A, Hagemeier FB, Velasquez WS, McLaughlin P, Redman J, Katz R, Butler JJ, Freireich EJ. Cytogenetic features of HD suggest possible origin from a lymphocyte. Blood 1988;71:1615-7.
48. Hangaishi A, Ogawa S, Mitani K, Hosoya N, Chiba S, Yazaki Y, Hirai H. Mutations and loss of expression of a mismatch repair gene, hMLH1, in leukemia and lymphoma cell lines. Blood 1997;89:1740-7.
49. Gartenhaus R, Johns MM III, Wang P, Rai K, Sidransky D. Mutator phenotype in a subset of chronic lymphocytic leukemia. Blood 1996;87:38-41.
50. Mark Z, Toren A, Amariglio N, Schiby G, Brok-Simoni F, Rechavi G. Instability of dinucleotide repeats in Hodgkin's disease. Am J Hematol 1998;57:148-52.
51. Joos S, Otaño-Joos MI, Ziegler S, Bruderlein S, Manoir S, Bentz M, Moller P, Lichter P. Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene. Blood 1996;87:1571-8.
52. Bentz M, Barth TFE, Bruderlein S, Bock D, Schwerer MJ, Baudis M, Joos S, Viardot A, Feller AC, Muller-Hermelink H-K, Lichter P, Dohner H, et al. Gain of chromosome arm 9p is characteristic of primary mediastinal B-cell lymphoma (MBL): comprehensive molecular cytogenetic analysis and presentation of a novel MBL cell line. Genes Chromosomes Cancer 2001;30:393-401.